Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Mimio Health Commercially Launches Groundbreaking Biomimetic Based on the Science of Fasting to Promote Cellular Health and Longevity


News provided by

JDI

Oct 19, 2023, 09:00 ET

Share this article

Share toX

Share this article

Share toX


In addition to the commercial launch of Mimio, which unlocks the same cellular benefits of fasting without skipping a single meal, Mimio Health also announces $1.75M seed round

SAN FRANCISCO, Oct. 19, 2023 /PRNewswire-PRWeb/ -- Mimio Health, the biomimetic human health company, announced today the commercial launch of their flagship product, Mimio. Mimio is a biomimetic designed from human biology to unlock the cellular health and longevity benefits of long-term fasting, without needing to fast. By upregulating and enhancing these cellular processes, Mimio supercharges the body's natural restorative abilities.

The benefits of Mimio can include, but are not limited to, improved metabolic health, hunger control, increased energy and performance, enhanced mood and cognition, balanced inflammatory responses, and support for healthy aging.

Mimio is a biomimetic designed from human biology to unlock the cellular health and longevity benefits of long-term fasting, without needing to fast. By upregulating and enhancing these cellular processes, Mimio supercharges the body's natural restorative abilities.

Post this

Fasting has been shown across thousands of studies to be one of the most powerful ways to enhance health and promote longevity. Using fasting as a roadmap, Mimio Health's biomimetic research has studied and decoded the changes that happen in the body to activate this innate longevity bio-program.

"Biomimetics seek inspiration from nature, where millions of years of evolution have resulted in highly efficient and effective solutions to various problems. Focusing on harnessing each individual's own biology, we have closely studied the complex interplay of molecules along key pathways in the body and their compounding cellular benefits that are naturally activated during fasting," said founder and CEO, Dr. Chris Rhodes. "While fasting has extraordinary scientific backing to provide health and longevity benefits, it can be a difficult long-term lifestyle, and many people who do fast are not unlocking the full benefits. With Mimio, we have been able to elevate the same beneficial bioactive metabolites that are produced during a prolonged fast without needing to skip a meal."

By mimicking our bodies' natural processes, Mimio's biomimetic is designed to upregulate and enhance multiple cellular systems, such as autophagy, metabolic efficiency, and cellular repair and protection, that are typically activated during fasting. Based on years of clinical research at UC Davis studying the underlying biology of fasting, Mimio's team discovered their proprietary blend of four bioactives (Spermidine, Nicotinamide, Palmitoylethanolamide (PEA), and Oleoylethanolamide (OEA)) that were uniquely elevated in the body during a 36-hour fast. Together, these fasting metabolites work synergistically to activate the cell's built-in health pathways and unlock both the body's innate regenerative abilities and compounding cellular benefits without needing to skip a meal.

"Our scientific mission to study, decode, and activate human biology has led us to this remarkable discovery, with much more to come," continued Dr. Rhodes. "The potential of our biomimetic research to uncover safe and effective bioactive molecules with direct impacts on human health is unparalleled and I can't wait for what's on the horizon. I'm humbled to be in a position where my research is making a difference in people's daily wellness, allowing them to harness the power of their own biology to live fuller, healthier lives."

The science behind Mimio is validated by a recent peer-reviewed clinical study authored by Dr. Chris Rhodes et al. and published by The American Journal of Clinical Nutrition. Moreover, the bioactive ingredients in Mimio's formulation have been validated in over 100 clinical studies to achieve whole-body benefits.

"Mimio is a truly game-changing company in the human health and optimization space. As an ultrarunner always looking for a performance edge, I am faced with some of the most demanding physical challenges in the world," said Charlie Engle, American ultramarathon runner and author. "I'm consistently impressed with Mimio's ability to enhance my energy, motivation, endurance, and recovery."

In addition to their new formulation, Mimio Health also announced a $1.75M Seed round led by Better Ventures, with participation by SOSV, Thia Ventures, What If Ventures, R42, and Gaingels. With the new funds, Mimio Health will continue to expand their product lines, perform additional clinical research, and continue their discovery efforts to identify novel biomimetic formulations.

Mimio is available now for purchase at http://www.mimiohealth.com.

About Mimio Health

Mimio Health is the biomimetic human health company. We harness the power of human biology to supercharge the body's natural restorative abilities.

Our flagship product, Mimio, is a biomimetic designed to activate our cells' built-in regenerative abilities to clean, repair, and protect themselves. By tapping into thousands of years of evolutionary knowledge about how key molecules are designed to optimally interact, Mimio's biomimetic ingredients work together to upregulate and enhance various cellular processes that were previously only accessible through fasting. The resulting physical and cognitive benefits include improved metabolic health, increased energy and performance, enhanced mood and focus, balanced inflammatory responses, and optimized healthy aging.

Mimio seamlessly blends into your daily care routine, whether you currently fast and are looking to enhance the results, or are simply looking for a way to take care of your body at a cellular level without skipping a single meal.

Mimio's founder, Dr. Chris Rhodes' scientific curiosity has always led him back to longevity. Mimio was inspired by his doctorate research and study of the underlying biology of fasting and its impact on longevity.

To learn more or to try Mimio yourself, please visit: mimiohealth.com.

Mimio Health. Your biology. Your superpower.

Media Contact

Cameron Gordon, JDI, (410) 504-9380, [email protected]

SOURCE JDI

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.